The Phase II trial for an Israeli COVID drug saw some 29 out of 30 patients, moderate to serious, recover within days.
Damn Jews.
www.jpost.com
Damn Jews.
COVID: 90% of patients treated with new Israeli drug discharged in 5 days
The Phase II trial for an Israeli COVID drug saw some 29 out of 30 patients, moderate to serious, recover within days.
![www.jpost.com](https://images.jpost.com/image/upload/f_auto,fl_lossy/Icons/PNG/jp-favicon-16.png)